UPDATED Sep 01, 2025
Discover Global Pharmaceuticals & Biotech Growth Stocks from around the world. Sorted by forecasted growth, these Pharmaceuticals & Biotech Stocks have higher than expected earnings or sales growth compared to other companies.
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
|---|---|---|---|---|---|---|---|---|---|---|
STRO | US$0.86 | -4.7% | -80.4% | US$72.7m | US$3.11 | PE-0.3x | E21.3% | n/a | ||
688073 | CN¥67.87 | 1.0% | 132.4% | CN¥5.9b | CN¥50.00 | PE42.1x | E21.3% | 1.3% | ||
SANOFICONR | ₹5,090.00 | -1.5% | n/a | ₹117.2b | ₹5,855.00 | PE58.6x | E21.3% | 1.1% | ||
LLY | US$732.58 | -0.5% | -23.4% | US$657.7b | US$888.52 | PE47.7x | E21.2% | 0.8% | ||
XFOR | US$3.76 | -5.4% | -82.1% | US$84.3m | US$19.75 | PS2.6x | E21.2% | n/a | ||
300181 | CN¥18.90 | -5.2% | 45.8% | CN¥13.1b | CN¥24.00 | PE22.4x | E21.2% | 3.2% | ||
IMP | ₫53,800.00 | 2.3% | 22.6% | ₫8.3t | ₫44,600.00 | PE25.2x | E21.2% | 0.9% | ||
IRON | US$59.65 | 0.4% | 17.4% | US$2.1b | US$99.73 | PB3.4x | E21.1% | n/a | ||
600422 | CN¥14.26 | -1.5% | 4.5% | CN¥10.8b | CN¥20.90 | PE18.8x | E21.1% | 2.1% | ||
CRMD | US$14.83 | 6.0% | 153.9% | US$1.1b | US$20.00 | PE21.6x | E21.0% | n/a | ||
301393 | CN¥57.99 | -3.2% | 59.0% | CN¥6.2b | CN¥60.00 | PE44.6x | E20.9% | 0.7% | ||
2162 | HK$71.90 | 0.9% | 102.5% | HK$21.2b | HK$76.31 | PS22.2x | E20.8% | n/a | ||
PRAX | US$45.54 | -4.9% | -17.8% | US$958.4m | US$99.67 | PS123.4x | E20.8% | n/a | ||
2561 | HK$45.18 | -2.3% | n/a | HK$5.1b | HK$82.02 | PS1696x | E20.7% | n/a | ||
SUPRIYA | ₹663.60 | 0.2% | 24.9% | ₹53.4b | ₹800.00 | PE30x | E20.7% | 0.2% | ||
ABEO | US$6.83 | -2.6% | 19.8% | US$350.2m | US$20.50 | PE6.1x | E20.6% | n/a | ||
532482 | ₹515.15 | 11.7% | -24.7% | ₹125.0b | ₹573.71 | PE26.1x | E20.6% | 0.3% | ||
LONN | CHF 571.00 | -0.3% | 4.0% | CHF 40.3b | CHF 665.36 | PE55x | E20.6% | 0.7% | ||
ERF | €64.98 | -2.6% | 27.0% | €11.5b | €63.93 | PE30.3x | E20.5% | 0.9% | ||
PVLA | US$54.15 | 8.0% | n/a | US$598.9m | US$62.75 | PB12.5x | E20.4% | n/a | ||
PAHC | US$37.07 | 16.1% | 76.5% | US$1.5b | US$32.50 | PE31.1x | E20.4% | 1.3% | ||
MANKIND | ₹2,520.90 | -1.4% | 5.4% | ₹1.0t | ₹2,799.65 | PE55x | E20.4% | 0.08% | ||
MARI | €20.00 | 1.0% | 266.3% | €35.6m | €46.00 | PS7.4x | E20.2% | n/a | ||
FF | €8.72 | -1.1% | 5.6% | €213.2m | €12.07 | PE17.1x | E20.1% | 1.6% |